The effort needed to optimize these regimens can be experienced as aversive, promote frustration, and generate a desire to avoid such effort, aligning with a region of the brain called the anterior midcingulate cortex, as described by Lisa Feldman Barrett and colleagues
abolishing obesity-related haemodynamic impairment, pathological LV remodelling and myocardial inflammation
In the Phase 3 TRANSCEND-T2D-1 trial of patients with diabetes, patients who took retatrutide achieved A1C reductions of up to 2%, with weight loss of 36.6 pounds or 16.8% at 40 weeks
The clinical evidence is compelling
The Financial Advantage of Gastric Sleeve Over GLP-1 Drugs This is where the conversation gets even more practical
Recent advancements have focused on enhancing its efficacy through novel delivery systems